Effect of short-term intensive therapy with glimepiride and metformin in newly diagnosed type 2 diabetic patients / 南方医科大学学报

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the effect of short-term intensive therapy on blood glucose control, BETA-cell function, and blood lipid levels in newly diagnosed type 2 diabetic patients.</p><p><b>METHODS</b>Out-patients with newly diagnosed type 2 diabetic patients were enrolled for intensive treatment with sulfonylureas and metformin for 12 weeks, and the therapeutic effect was evaluated.</p><p><b>RESULTS</b>After the intensive treatment, FPG, 2 hPG, and HbA1c decreased significantly (P<0.01); HOMA-IR decreased and HOMA-B increased significantly (P<0.01), and TG, CHOL, LDL decreased significantly (P<0.01) after the treatment.</p><p><b>CONCLUSION</b>Short-term intensive treatment with glimepiride combined with metformin is safe and effective in newly diagnosed type 2 diabetic patients with HbA1c>9%.</p>